Back to PFE Stock Lookup

Pfizer (PFE) – Press Releases

Jan 19, 2017 08:00 AM Milner Therapeutics Institute Announces New Partnership with US Pharmaceutical Company Pfizer
Jan 10, 2017 01:00 PM The Scripps Research Institute Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library Technology
Jan 5, 2017 04:05 PM ICU Medical, Inc. Provides Update on Hospira Infusion Systems Transaction
Jan 5, 2017 09:00 AM AbCellera Announces Multi-Target Research Collaboration with Pfizer
Jan 5, 2017 08:30 AM Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira®1 (adalimumab)
Jan 5, 2017 06:00 AM Molecular Stethoscope Completes $8.2M Seed Financing to Advance Circulating Cell-Free RNA Liquid Biopsy Platform; Announces Research Collaboration with Pfizer
Jan 4, 2017 07:30 AM Spark Therapeutics Announces $15 Million Milestone Payment from Pfizer for Progress in Hemophilia B Gene Therapy Program
Jan 3, 2017 11:00 AM Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts
Jan 3, 2017 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Dec 23, 2016 02:05 AM Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca
Dec 21, 2016 08:30 AM Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
Dec 21, 2016 08:00 AM FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2- Metastatic Breast Cancer
Dec 21, 2016 07:00 AM Circle Pharma, Developer of Macrocyclic Peptide Therapeutics, Announces Series A Financing and Appoints Walter H. Moos, Ph.D., to Its Board
Dec 21, 2016 05:14 AM BioInvent Announces Cancer Immunotherapy Research Collaboration and License Agreement With Pfizer and Issues New Shares to Pfizer
Dec 20, 2016 07:00 AM Draper to Build Preclinical Microphysiological Systems with Pfizer to Help Predict Clinical Outcomes
Dec 19, 2016 08:00 AM Portola Pharmaceuticals Enters into $50 Million Loan Agreement with Bristol-Myers Squibb and Pfizer for Continued Development of AndexXa™ (andexanet alfa)
Dec 19, 2016 07:00 AM Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) in Infants Six Weeks of Age and Older
Dec 16, 2016 02:09 PM FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX® (varenicline) Labeling
Dec 14, 2016 07:34 PM Pfizer Receives FDA Approval for EUCRISATM (crisaborole), a Novel Non-Steroidal Topical Ointment for Mild to Moderate Atopic Dermatitis (Eczema)
Dec 14, 2016 04:30 PM Sheridan Memorial Hospital First to Implement Interoperable Alarm Technology Between Cerner and Hospira
Dec 14, 2016 04:15 PM Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide) Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer
Dec 13, 2016 01:03 PM Ab Initio Announces Strategic Collaboration with Pfizer to Discover GPCR Activating Antibodies
Dec 12, 2016 11:53 AM Pfizer Declares First-Quarter 2017 Dividend
Dec 12, 2016 08:00 AM Pioneers in Oncolytic Virus and Gene Therapy Fields Announce Formation of IGNITE Immunotherapy Inc., a Company Focused on Oncolytic Cancer Vaccine Discovery and Development
Dec 9, 2016 11:30 AM Akili and Pfizer Present Positive Data from Digital Biomarker Study to Detect Subtle Cognitive Changes in Healthy Subjects at Risk of Developing Alzheimer’s Disease
Dec 6, 2016 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Dec 5, 2016 08:00 AM Pfizer and Avillion Announce Positive Top-Line Results for Phase 3 BFORE Study of BOSULIF for First-Line Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia
Dec 3, 2016 01:00 PM New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Dec 3, 2016 11:00 AM Spark Therapeutics and Pfizer Present Updated Preliminary Data from Hemophilia B Phase 1/2 Trial Suggesting Consistent and Sustained Levels of Factor IX Activity at Annual ASH Meeting
Dec 1, 2016 10:00 AM Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
Dec 1, 2016 08:00 AM LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint
Dec 1, 2016 08:00 AM IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
Dec 1, 2016 08:00 AM IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
Nov 30, 2016 04:01 PM Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software
Nov 30, 2016 08:30 AM Pfizer Announces Positive Top-Line Results from the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014, a Potential Biosimilar to Herceptin®1 (trastuzumab)
Nov 29, 2016 08:17 AM FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
Nov 21, 2016 10:11 AM Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire
Nov 21, 2016 06:45 AM Pfizer Announces Expiration And Results Of Tender Offer For Any And All Of Its 6.200% Senior Notes Due March 15, 2019
Nov 18, 2016 02:55 PM Pfizer Announces Pricing of Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019
Nov 16, 2016 05:09 PM PALOMA-2 Phase 3 Study Published In The New England Journal Of Medicine Demonstrates Clinical Benefit Of Pfizer’s IBRANCE® (palbociclib) In First-Line ER+, HER2- Metastatic Breast Cancer
Nov 15, 2016 08:00 AM Pfizer Announces Results from Phase 3 OPAL Clinical Development Program Investigating XELJANZ® (Tofacitinib Citrate) for Psoriatic Arthritis
Nov 14, 2016 06:55 PM Pfizer Prices $6,000,000,000 Debt Offering
Nov 14, 2016 08:47 AM Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019
Nov 14, 2016 08:00 AM Pfizer to Collaborate with National Cancer Institute to Study Three Immunotherapy Agents Targeting Multiple Cancers
Nov 13, 2016 04:57 PM Landmark Study Demonstrates Pfizer’s Celebrex (Celecoxib)Has Similar Cardiovascular Risk As Compared To Prescription Doses Of Ibuprofen and Naproxen
Nov 11, 2016 06:00 AM Pfizer Announces Major Expansion of Humanitarian Assistance Program
Nov 10, 2016 07:59 AM Bristol-Myers Squibb and Pfizer to Deliver 12 New Eliquis® (apixaban) Presentations at American Heart Association (AHA) Scientific Sessions 2016
Nov 10, 2016 02:00 AM IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer
Nov 7, 2016 06:45 AM Pfizer to Present Additional Research For XELJANZ® (Tofacitinib Citrate) In Rheumatologic Diseases, Including Rheumatoid Arthritis and Psoriatic Arthritis
Nov 3, 2016 04:08 PM TherapeuticsMD Expands Commercial and Business Development Leadership

Back to PFE Stock Lookup